Compare Revvity Inc (RVTY) vs Uranium Energy Corp (UEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Uranium Energy Corp — how do they compare? Revvity Inc trades at $124.14 (market cap $13.82B), while Uranium Energy Corp trades at $11.63 (market cap $5.74B). The key difference: Revvity Inc is far larger — about 2.4× Uranium Energy Corp's market cap, and Revvity Inc pays a 0.23% dividend while Uranium Energy Corp pays none. Which is the better fit depends on your goals.
| RVTY | UEC | |
|---|---|---|
Market Cap | $13.82B | $5.74B |
Sector | Technology | Energy |
52-Week High | $130.94 | $20.14 |
52-Week Low | $82.26 | $9.04 |
Enterprise Value | $16.14B | $5.25B |
Dividend Yield | 0.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
UEC is trading at $11.89, up 3.03% today, with a bullish technical signal despite negative profitability metrics. The company reported a net loss of $87.66 million in 2025 with revenue of $66.84 million, though it beat Q4 2025 EPS expectations. Analyst sentiment remains strongly positive with 87.5% buy ratings, supported by institutional interest including BlackRock's recent $432.68 million investment.
The outlook for UEC is mixed, with strong analyst support and nuclear energy tailwinds offset by persistent losses and negative margins. Key risks include execution challenges and uranium price volatility, while opportunities lie in the growing nuclear power sector and institutional backing. The stock trades near recent support levels with technical indicators suggesting potential near-term strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →
